Open an Account
search icon
4
NOTIFICATIONS
Best Algo trading app in India
Bigul

BLISS GVS PHARMA LTD. - 506197 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate

 Pursuant to Regulation 39(3) of Securities Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, this is to inform you that the Registrar and Share Transfer Agent of the Company M/s. Universal Capital Securities Private Limited have received a request to issue of duplicate share certificate consequent to loss of share certificate from the shareholder.
01-07-2023
Bigul

BLISS GVS PHARMA LTD. - 506197 - Announcement under Regulation 30 (LODR)-Newspaper Publication

 Pursuant to Regulation 30 and 47 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, please find enclosed copies of newspaper advertisement pertaining to the Notice of 38th Annual General Meeting of the Company scheduled to be held on Wednesday, July 19, 2023 at 11:00 a.m. (IST) through Video Conferencing/Other Audio-Visual Means, e-Voting details, and Book Closure information. The above advertisement was published on June 30, 2023, in "The Economics Times, The Free Press Journal, Maharashtra Times, and Navshakti" newsapapers. This is for your information and record.
01-07-2023
Bigul

BLISS GVS PHARMA LTD. - 506197 - Closure of Trading Window

 This is to inform you that pursuant to the Securities Exchange Board of India (Prohibition of Insider Trading) Regulations, 2015 (including any statutory modification(s) or re-enactment(s) thereof, for the time being in force) and in accordance with the Code of Internal Procedures and Conduct for Regulating, Monitoring and Reporting of Trading by the Designated Persons, the Trading window for dealing in securities/shares of Bliss GVS Pharma Limited ("the Company") will remain closed for Insiders, Designated Persons and their immediate relatives of the Company with effect from Saturday, July 01, 2023 till completion of 48 hours after the announcement of the Unaudited Financial Results of the Company for the quarter ended on June 30, 2023 generally made available to the public.
30-06-2023
Bigul

BLISS GVS PHARMA LTD. - 506197 - Reg. 34 (1) Annual Report.

 This is further to our letter dated May 11, 2023, wherein the Company had informed that the 38th Annual General Meeting (38th AGM) of the Company is scheduled to be held on Wednesday, July 19, 2023, through Video Conference/Other Audio-Visual Means, in accordance, with the relevant circulars issued by Ministry of Corporate Affairs and Securities and Exchange Board of India (SEBI). Pursuant to Regulation 34(1) of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 ('SEBI Listing Regulations'), please find enclosed the Notice convening the 38th AGM and the Annual Report of the Company including Business Responsibility and Sustainability Report, for the financial year 2022-2023.
27-06-2023
Bigul

BLISS GVS PHARMA LTD. - 506197 - Business Responsibility and Sustainability Reporting (BRSR)

 Pursuant to Regulation 34(2)(f) of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, as amended, please find enclosed the Business Responsibility and Sustainability Report for the financial year 2022-2023, which forms an integral part of the Annual Report for the financial year 2022-2023.
27-06-2023
Bigul

BLISS GVS PHARMA LTD. - 506197 - Notice Of The 38Th Annual General Meeting Of Bliss GVS Pharma Limited

 Pursuant to Regulation 30 read with Para A, Part A of Schedule III of the SEBI Listing Regulations, 2015, please find enclosed herewith the Notice of the 38th AGM of Bliss GVS Pharma Limited scheduled to be held on Wednesday, July 19, 2023, at 11:00 a.m. (IST) through Video Conference/Other Audio-Visual Means.
27-06-2023
Bigul

BLISS GVS PHARMA LTD. - 506197 - Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPS

 We would like to inform you that, the ESOP Allotment Committee of the Company at its meeting held on June 23, 2023, has approved the allotment of 26,000 equity shares of face value of Re. 1/- each to the eligible employees who have exercised their stock options under Bliss GVS Pharma Limited-Employee Stock Option Plan 2019 ('Bliss GVS ESOP-2019').
23-06-2023
Bigul

BLISS GVS PHARMA LTD. - 506197 - Announcement under Regulation 30 (LODR)-Newspaper Publication

 Pursuant to Regulation 30 and Regulation 47 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, please find enclosed herewith copies of the newspaper advertisement in the interest of the shareholders regarding the intimation of 38th Annual General Meeting of the Company scheduled to be held on Wednesday, July 19, 2023, at 11:00 a.m. (IST) through Video Conferencing ('VC")/Other Audio Visual Means ('OAVM'), in compliance with the General Circulars dated April 08, 2020, April 13, 2020, May 05, 2020, January 13, 2021, December 08, 2021, December 14, 2021, May 05, 2022, and December 28, 2022, respectively issued by the Ministry of Corporate Affairs ('MCA Circulars') along with the Circular issued by Securities and Exchange Board of India ('SEBI Circular') dated May 12, 2020, January 15, 2021, May 13, 2022, and January 05, 2023, published in Economic Times, FPJ, Maharashtra Times and Navshakti newspapers on June 23, 2023.
23-06-2023
Bigul

BLISS GVS PHARMA LTD. - 506197 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate

 Pursuant to Regulation 39(3) of Securities Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, this is to inform you that the Registrar and Share Transfer Agent of Company M/s. Universal Capital Securities Private Limited have received a request to issue of duplicate share certificate consequent to loss of share certificate from the shareholder.
19-06-2023
Bigul

BLISS GVS PHARMA LTD. - 506197 - Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011

 The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Dr Vibha Gagan Sharma & PACs
19-06-2023
Next Page
Close

Let's Open Free Demat Account